Aspect biosystems and novo nordisk enter partnership to develop bioprinted tissue therapeutics for diabetes and obesity

Partnership will leverage aspect's proprietary bioprinting technology and novo nordisk's expertise and technology in stem cell differentiation and cell therapy development and manufacturing .

NVO Ratings Summary

NVO Quant Ranking